DataBreachCaseSearch.com

Tris Pharma data breach

Tris Pharma, an Indiana-based company, reported a data security incident on December 4, 2025, which occurred on September 24, 2025. This event may have exposed personal information, and an investigation is currently underway to determine the full scope. Individuals who received a notification letter should understand their options regarding the potential compromise of their data.

Docket sheet

Company
Tris Pharma
Venue
IN Attorney General
Filed
December 4, 2025
People affected
Not stated
Status
Investigation Open
Official regulator filing

Where this breach stands

  1. 1

    Breach occurredSeptember 24, 2025

    Date of the incident as stated in the filing.

  2. 2

    Reported to the IN Attorney GeneralDecember 4, 2025

    The company filed a breach notification with the state regulator.

  3. 3

    Attorney reviewCurrent stage

    Current status: Investigation Open. Our office is reviewing whether affected people may have claims.

  4. 4

    Your case review

    Got a letter about this breach? Submit it for a free, confidential review.

Clerk's notes

Tris Pharma, an entity based in Indiana, officially reported a data security event on December 4, 2025. This incident, which first occurred on September 24, 2025, potentially involved unauthorized access to systems containing personal information. The specific nature of how this breach happened has not been publicly detailed at this time.

While the precise categories of personal information affected are not specified in the public record, individuals who received a notification letter from Tris Pharma should carefully review its contents. An internal investigation is currently in progress to ascertain the full extent of the data exposure and to identify all potentially impacted individuals.

For those who received a direct notification regarding this incident, it is prudent to remain vigilant. Review all official communications from Tris Pharma for further details. Consider monitoring your accounts and financial statements for any unusual activity.

Understanding the implications of a data breach can be complex. If you believe your personal information may have been compromised due to the Tris Pharma incident, you may wish to seek a free, no-obligation case review to discuss your situation and potential next steps.

If a notification letter about this breach reached you, see every IN data breach on file or browse all cases.

Other IN docket entries

Attorney advertising. A docket entry reflects a public regulator filing and our review status; it does not mean a lawsuit has been filed. Submitting a review request does not create an attorney-client relationship.